Tibet Cheezheng Tibetan Medicine Co Ltd
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculo… Read more
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.007x
Based on the latest financial reports, Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a cash flow conversion efficiency ratio of 0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥34.69 Million) by net assets (CN¥4.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tibet Cheezheng Tibetan Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Tibet Cheezheng Tibetan Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tibet Cheezheng Tibetan Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tibet Cheezheng Tibetan Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
N/A |
|
Semler Scientific Inc
NASDAQ:SMLR
|
-0.072x |
|
OPUS GLOBAL Nyrt
BUD:OPUS
|
0.077x |
|
SK Networks Co Ltd
KO:001740
|
0.035x |
|
ThredUp Inc
NASDAQ:TDUP
|
0.102x |
|
Hubei Sanxia New Building Materials Co Ltd
SHG:600293
|
-0.007x |
|
ZEAL Network SE
XETRA:TIMA
|
0.163x |
|
Johnson Health Tech Co Ltd
TW:1736
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.11 Billion | CN¥456.75 Million | 0.111x | -39.62% |
| 2023-12-31 | CN¥3.77 Billion | CN¥693.41 Million | 0.184x | +118.09% |
| 2022-12-31 | CN¥3.39 Billion | CN¥285.69 Million | 0.084x | -73.76% |
| 2021-12-31 | CN¥3.22 Billion | CN¥1.03 Billion | 0.321x | +254.77% |
| 2020-12-31 | CN¥2.63 Billion | CN¥238.65 Million | 0.091x | -49.53% |
| 2019-12-31 | CN¥2.26 Billion | CN¥405.95 Million | 0.179x | -26.50% |
| 2018-12-31 | CN¥2.05 Billion | CN¥499.40 Million | 0.244x | +101.20% |
| 2017-12-31 | CN¥1.89 Billion | CN¥229.83 Million | 0.121x | -45.39% |
| 2016-12-31 | CN¥1.75 Billion | CN¥389.20 Million | 0.222x | +42.32% |
| 2015-12-31 | CN¥1.65 Billion | CN¥257.81 Million | 0.156x | -22.18% |
| 2014-12-31 | CN¥1.55 Billion | CN¥310.95 Million | 0.201x | +46.41% |
| 2013-12-31 | CN¥1.45 Billion | CN¥198.48 Million | 0.137x | +9.18% |
| 2012-12-31 | CN¥1.35 Billion | CN¥169.67 Million | 0.126x | +1466.31% |
| 2011-12-31 | CN¥1.28 Billion | CN¥-11.74 Million | -0.009x | -111.47% |
| 2010-12-31 | CN¥1.21 Billion | CN¥96.91 Million | 0.080x | -47.76% |
| 2009-12-31 | CN¥1.14 Billion | CN¥175.58 Million | 0.153x | +23.84% |
| 2008-12-31 | CN¥532.28 Million | CN¥65.93 Million | 0.124x | -46.31% |
| 2007-12-31 | CN¥396.33 Million | CN¥91.43 Million | 0.231x | +173.63% |
| 2006-12-31 | CN¥456.61 Million | CN¥38.50 Million | 0.084x | -- |